Innovative Stem Cell Case Series for Atrophic Scars Launches Through Collaboration Between Vega Stem Cell, Chulalongkorn University, and JJN Clinic

Vega Stem Cell has initiated a groundbreaking case series investigating the combined effects of stem cell therapy, microneedling, and targeted peptide treatment to improve atrophic scars, a condition impacting millions globally. This collaborative effort unites three leading institutions: Vega Stem Cell, Dr. Apipon Methachittipan from Chulalongkorn University, and Dr. Pinyapat Techatraisak of JJN Clinic, blending academic research, clinical proficiency, and advanced regenerative techniques to develop an innovative approach addressing this common dermatological issue.

Addressing a Common Yet Complex Skin Condition

Atrophic scars, such as those resulting from acne, surgery, or injury, cause considerable cosmetic and psychological distress. Traditional treatments like laser therapy and dermabrasion often provide only limited improvement, particularly in severe cases. Stem cell therapy represents a significant advancement by promoting the regeneration of damaged skin at the cellular level.

This newly launched case series employs a combined regenerative approach including:

• Stem cell therapy to repair damaged skin tissue and stimulate collagen production
• Microneedling to create small controlled wounds that improve stem cell absorption and trigger the skin’s natural repair processes
• Peptides BPC-157 and PT-141 to control inflammation, encourage the formation of new blood vessels, and enhance cellular functions

This combination of therapies offers a synergistic effect that improves scar texture, pigmentation, and overall skin regeneration.

Stem Cell Therapy: The Core of the Protocol

Stem cell therapy employs mesenchymal stem cells (MSCs), which are recognized for their anti-inflammatory, anti-fibrotic, and collagen-stimulating effects. In this case series, the stem cells are injected into the scarred areas, where they:

• Promote the growth of fibroblasts
• Stimulate the formation of new blood vessels to improve local circulation
• Regulate inflammatory cytokines that hinder tissue repair
• Enhance the remodeling of the extracellular matrix

Microneedling: Boosting Efficacy Through Controlled Microtrauma

To enhance the absorption and effectiveness of stem cells, the case series includes microneedling—a minimally invasive method that uses tiny needles to create numerous micro-channels in the outer and deeper layers of the skin.
These small injuries trigger the body’s natural healing process and greatly improve the uptake and bioavailability of the injected stem cells and peptides. Additionally, this technique stimulates:

• The release of platelet-derived growth factors
• The activation of fibroblasts
• The production of collagen and elastin

Peptide Therapy: The Role of BPC-157 and PT-141

Peptides have attracted growing interest due to their ability to regulate cell signaling and healing processes. In this case series, two specific peptides are used to investigate their combined effect with stem cell therapy:

BPC-157 (Body Protection Compound)

• Known to stimulate new blood vessel formation and collagen production
• Helps reduce inflammation and speeds up wound healing
• Supports the stability of growth factors and the extracellular matrix, aiding scar repair

PT-141 (Bremelanotide)

• Although primarily used for sexual health, PT-141 shows potential in improving blood vessel remodeling and immune system regulation
• Increases blood flow to tissues, which may enhance oxygen and nutrient supply to scarred areas
• Promotes cellular functions that contribute to faster tissue regeneration

Collaborating Experts

This project represents a significant achievement in multidisciplinary regenerative medicine, bringing together experts from biotechnology, clinical dermatology, and biomedical engineering.

Vega Stem Cell
vegastemcell.com
Vega Stem Cell is a regenerative medicine center based in Thailand, specializing in stem cell therapies for orthopedics, anti-aging, ovarian rejuvenation, and skin repair. Renowned for innovative clinical protocols and strict adherence to international safety standards, Vega is continuously advancing the potential of stem cell treatments.

Dr. Apipon Methachittipan, PhD – Chulalongkorn University
A lecturer in the Department of Industrial and Systems Engineering, Dr. Methachittipan contributes expertise in treatment optimization, data analysis, and modeling of protocol efficiency.

Dr. Pinyapat Techatraisak (Dr. Gift) – JJN Clinic
A leading aesthetic physician in Thailand, Dr. Gift specializes in facial aesthetics, dermatological repair, and minimally invasive treatments. Her clinical experience at JJN Clinic makes her the ideal lead for administering stem cell and microneedling protocols.

Market Potential and Future Implications

The global scar treatment market is projected to exceed USD 34 billion by 2030. Developing an effective and reproducible stem cell-based therapy has the potential to transform scar management practices. The findings from this case series will provide a basis for larger clinical trials and pave the way for the adoption of comparable protocols in aesthetic and dermatological care globally.

A Vision for Evidence-Based Aesthetic Innovation

This collaboration demonstrates the power of interdisciplinary partnerships in translating scientific research into effective real-world applications. The initiative marks a significant step toward redefining the treatment of atrophic scars through stem cell treatments.

Contact Information

Vega Medical Services
3/6, The Primary 101, Soi Lad Phrao 101,
Lad Phrao Road, Khlong Chan, Bang Kapi District,
Bangkok 10240, Thailand

Email: vegastemcell@gmail.com
Tel & WhatsApp: +66 (0) 86 691 6915